Results 71 to 80 of about 5,756 (158)
Objective: To compare mean heart rate reduction in Ivabradine and placebo group in left ventricular failure patients. Study Design: Quasi experimental study.
Safia Batool +5 more
doaj
Abhijit S Nair, T V S Gopal
openaire +3 more sources
Risk-benefit assessment of ivabradine in the treatment of chronic heart failure
Irmina Urbanek, Krzysztof Kaczmarek, Iwona Cygankiewicz, Pawel PtaszynskiDepartment of Electrocardiology, Chair of Cardiology and Cardiosurgery, Medical University, Lodz, PolandAbstract: Heart rate is not only a major risk marker in heart failure but ...
Urbanek I +3 more
doaj
Ivabradine for Incessant Atrial Tachycardia in a 1-Year-Old Child After Tetralogy of Fallot Repair
Discussion: Ivabradine may be an option for incessant atrial tachycardia in pediatric patients. Although most tachyarrhythmias following TOF repair occur due to a reentry mechanism, focal mechanisms can also occur, suggested by timing, gradual ...
Haikal Balweel +5 more
doaj +1 more source
Aim. To compare endothelial function in patients with Stage I-II arterial hypertension (AH) and Functional Class (FC) II stable angina, receiving either beta-adrenoblocker (metoprolol tartrate) or If channel inhibitor (ivabradine), combined with ...
L. L. Kirichenko +5 more
doaj
Ivabradine in Postural Orthostatic Tachycardia Syndrome. Is That All We Need? [PDF]
Brasil HN +4 more
europepmc +1 more source
Impact of Once-Daily Ivabradine on Average Resting Heart Rate in Patients With Reduced Ejection Fraction With Systolic Dysfunction: A Multicenter, Post-marketing Observational Study. [PDF]
Mullasari A +6 more
europepmc +1 more source
A sustainable spectrofluorimetric method for ivabradine quantification based on erythrosin B quenching with quantum mechanical modeling and Box-Behnken design optimization. [PDF]
Alqahtani AS +7 more
europepmc +1 more source

